Alector, Inc. (ALEC) News

Alector, Inc. (ALEC): $24.26

-0.74 (-2.96%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ALEC to Watchlist
Sign Up

Industry: Biotech


Ranked

of NR

in industry

Filter ALEC News Items

ALEC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ALEC News Highlights

  • 500 - Internal server error
  • Over the past 15 days, the trend for ALEC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about ALEC are CNTG and DE.

Latest ALEC News From Around the Web

Below are the latest news stories about Alector Inc that investors may wish to consider to help them evaluate ALEC as an investment opportunity.

Centogene, Alector initiate EFRONT study in frontotemporal dementia

Centogene N.V. (CNTG) announces a new observational study to understand the prevalence of genetic mutations in patients with frontotemporal dementia ((FTD)).The observational EFRONT Study is being conducted with Alector (ALEC) under a commercial agreement.Financial details of the deal are not disclosed. The study aims to enroll and genetically test more...

Seeking Alpha | June 2, 2021

Alector: Pioneering Approach In CNS Diseases

Photo by libre de droit/iStock via Getty Images Alector (ALEC) harnesses genetic technology to target the immune system based on the hypothesis that the immune system causes neurodegeneration. Understandably, that's a lot of science thrown into one sentence - and one company. But Alector is a pioneer in immuno-neurology, and...

Avisol Capital Partners on Seeking Alpha | May 18, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7907 seconds.